| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |